semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Community Acquired Pneumonia Each subject must: 1. Be male or female at least 18 years of age. 2. Provide written informed consent and be willing and able to adhere to the study-specified procedures and restrictions. 3. Have an acute illness (less than or equal to 7 days duration) with at least 3 of the following symptoms consistent with a lower respiratory tract infection (new or worsening) Dyspnea New or increased cough Purulent sputum production Chest pain due to pneumonia. 4. Have at least 2 of the following vital sign abnormalities Fever (body temperature > 38.0 °C (100.4 °F) measured orally or equivalent temperature from an alternate body site) or hypothermia (body temperature < 35.0 °C (95.0 °F) measured orally or equivalent temperature from an alternate body site) Hypotension (systolic blood pressure < 90 mmHg) Tachycardia (heart rate > 100 beats/min) Tachypnea (respiratory rate > 20 breaths/min). 5. Have at least 1 other clinical sign or laboratory finding of CABP Hypoxemia (i.e., O2 saturation < 90 % on room air or while receiving supplemental oxygen at subject's baseline requirement or PaO2 < 60 mmHg)  Each subject must NOT: 1. Have received more than a single dose of a short-acting oral or IV antibacterial for CABP within 72 hours before randomization. 2. Require concomitant systemic antibacterial therapy potentially effective against CABP pathogens. 3. Have been hospitalized for 2 or more days within 90 days prior to the onset of symptoms or have resided in a nursing home or long-term healthcare facility within 30 days prior to the onset of symptoms. NOTE: Residence in an independent living facility is permitted. 4. Have confirmed or suspected CABP caused by a pathogen known to be resistant to any of the study drugs (e.g., MRSA, Pseudomonas aeruginosa, any pathogen of the Enterobacteriaceae Family) or attributable to etiologies other than community acquired bacterial pathogens (e.g., ventilator associated pneumonia, hospital acquired bacterial pneumonia, bacterial aspiration pneumonia, Pneumocystis jiroveci pneumonia or other fungal pneumonia, viral or mycobacterial infection of the lung). 5. Have a noninfectious cause of pulmonary infiltrates (e.g., pulmonary embolism, chemical pneumonitis from aspiration, hypersensitivity pneumonia, congestive heart failure, bronchial obstruction, lung cancer, cystic fibrosis). 6. Have confirmed or suspected pleural empyema (does not sterile parapneumonic effusions)
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chronic Pain Adhesions Patients aged 18 years and above with chronic abdominal pain that was likely to be caused by adhesions due to previous abdominal surgery were recruited. Before attributing abdominal pain to the existence of adhesions all patients had an extensional diagnostic work-up to other pathology  Current treatment by psychologist or psychiatrist Use of laxatives, sedatives, morphine, antipsychotics, antidepressants, or drugs that stimulate the central nervous system Abnormal outcome of standardized non-invasive diagnostics Biochemical investigation Lactose tolerance tests or H2 respiration test Feces analysis of worms and worm eggs Ultrasound or CT scan of the abdomen Radiographic studies of small and large bowel (or colonoscopy)
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Clostridium Difficile Antibiotic-induced diarrhea Positive fecal analysis for Clostridium difficile toxin  Antibiotic treatment Probiotic treatment Intestinal infection other than Clostridium difficile Inflammatory bowel disease (Ulcerative colitis, Crohn's disease Immunodeficiency (drug och disease-related) Pregnancy Unable to accept endoscopic procedures Unable to give informed consent
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Local Anaesthesia ASA(American society of anesthesia) I, II , consent, forearm or arm surgery  ASA(American society of anesthesia) III or more, allergy, refusal
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Arrhythmias, Cardiac Tachycardia, Ventricular Ventricular Fibrillation Defibrillators, Implantable Diagnosis of ES (documentation of 3 or more episodes of sustained ventricular arrhythmia within 24h or documentation of sustained ventricular tachycardia lasted at least 12h).In order to fulfill this criterion, a patient with a previous episode of ES could also be enrolled during routine screening Age ≥18 Written informed consent  patient without ICD Confirmed or suspected use of drugs or narcotics with known direct pro-arrhythmic effect Inability to express an informed consent for the study
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Clostridium Difficile Male or female hospitalized patient. 2. Aged ≥ 50 years old. 3. Initiation of intravenous or oral treatment with intended duration ≥5 days (≥1 day for clindamycin) with at least one of the following antibiotic classes, or treatment scheduled within the next 72 hours Third or fourth generation cephalosporins Fluoroquinolones Penicillins +beta-lactamase inhibitors Clindamycin Carbapenems 4. Written informed consent provided prior to inclusion  Ongoing antibiotic treatment with one of the above classes initiated >6 hours before into the study. 2. ICU admission at the time of or anticipated admission within 48h. 3. Suspected or diagnosed CDI, ongoing treatment for CDI, or diarrhoea at the time of inclusion. 4. Patient with stoma. 5. Subject has been included into this study previously. 6. Patient treated with probiotics to prevent CDI. 7. Patient with any social or logistical condition which in the opinion of the investigator may interfere with the conduct of the study, such as incapacity to well understand, not willing to collaborate, or cannot easily be contacted after discharge. 8. Subject is subject to legal protection. 9. Subject deprived of liberty by judicial or administrative decision
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-14.0,  Community-Acquired Infections Children 0-14 years of age presenting with an acute febrile illness with a temperature of more than or equal to 38 degrees C or hypothermia (temperature less than 36 degrees C) with any of the following symptoms; convulsion, respiratory distress, prostration or non-traumatic circulatory collapse to the pediatric outpatient or emergency pediatric units of participating Nigerian institutions  No consent obtained/withdrawal of consent, known congenital heart disease, bronchial asthma, or recent hospitalizations within the past 2 weeks
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Clostridium Difficile Infection Unformed Stool specimens from patients suspected of having CDI for whom diagnostic tests are indicated and ordered At least 1.25mL of unformed stool specimen (defined as specimen assuming the shape of its container) Only one (1) specimen per patient will be included in the study Materials use within their expiration date Transport, storage times, and conditions (e.g. room temperature and/or refrigerated) within requested indications  Specimens from patients for whom CDI diagnostic tests have not been ordered Transport and storage times and conditions that exceed these Study Protocol requirements Formed or hard stool specimens or rectal swabs
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Valvular Heart Disease Stenosis and Regurgitation (Diagnosis) Presence of aortic stenosis, mitral or aortic regurgitation at the time of an echocardiography at the "Cliniques Universitaires Saint Luc"
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Diarrhea Immunosuppression Male and female patients between the ages of 18 and 75 years old who are solid organ transplant recipients followed at Toronto General Hospital on MMF referred to gastroenterology for diarrhea  Subjects with a known history of IBD or GVHD of the bowel. 2. Any subject receiving Octreotide for another indication. 3. Any patient unable to undergo endoscopy. 4. Any patient with a contraindication to Octreotide therapy
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 3.0-18.0,  Neutropenia, Febrile Pediatric Cancer All pediatric febrile neutropenia patients treated on outpatient basis Age 3 years years Fulfilling low risk ( Hematological malignancies in remission, No identifiable focus of infection, No Pneumonia/ mucositis / GI sepsis / Nausea-vomiting/ neurologic-mental status changes/ Central Venous Catheter (CVC) related infection, Anticipated Absolute Neutrophil Count (ANC) recovery ≤ 10 days, No organ dysfunction, Hemodynamically stable, Culture negative ) Afebrile for at least 24 hours, on intra-venous antibiotics  Bone marrow involvement in solid tumor Already enrolled once, in previous episode On antibiotics prophylaxis Retroviral positive patients Patient undergone stem cell transplant
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Infection One or more episodes recurrent CDI (defined as > 3 loose/watery stools/24h for 2 consecutive days with CDI treatment, and not explained by another diagnosis PLUS laboratory confirmation of C. difficile; or ileus, or toxic megacolon PLUS laboratory confirmation of C. difficile, occurring within 90 days of a prior CDI episode with similar symptoms and laboratory confirmation) 2. Resolution or improvement of symptoms from most recent CDI episode, defined as no longer meeting the clinical definition for CDI for a 48 hour period during treatment, including not meeting the definition again after an initial improvement 3. Within the enrollment window: 2 days after completion of antimicrobial therapy for CDI (to allow for a washout period) to 14 days after completion of therapy or 30 days after the onset of CDI whichever is later. 4. Age 18 years 5. Enrolled in a VHA facility 6. Able and willing to provide informed consent  Unlikely to swallow capsules 2. Pregnancy, planning to be pregnant, or breastfeeding 3. Receipt of cytotoxic chemotherapy, intravenous or subcutaneous immune globulin, or confirmed neutropenia (absolute neutrophil count of < 1,000 cells/ L) within the past 3 months 4. Inflammatory bowel disease or other chronic diarrheal disease/fecal incontinence predating CDI 5. Ongoing antibiotic use other than those for the current episode of CDI 6. Prior FMT 7. Life expectancy of < 8 weeks 8. Anaphylactic food allergy 9. Active enrollment in another research study on antibiotics, probiotics, or FMT without investigators approval 10. Presence of an ileostomy or colostomy 11. HIV with CD4 count < 200 cells/�L in prior 3 months 12. Decompensated cirrhosis 13. Bone marrow/peripheral blood stem cell transplant in the past year 14. Unlikely to follow study protocol
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Postoperative Pain Scheduled for unilateral, primary total hip replacement American Society of Anesthesiologists physical status 1-3  Pregnancy Currently Workman's Comp litigation related to hip replacement Taking greater than 100 milligrams of morphine (or equivalent) Suffering from a psychotic disorder or a recent psychiatric hospitalization
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abdomen, Acute Renal Colic Patients over 18 years old Patient presenting acute abdominal pain since 7 days or less Need of blood sample confirmed by physician Affiliation to french social security system Informed Consent  Post traumatic abdominal pain / occurrence of abdominal trauma in the 7 days before ED visit Patients with cirrhosis classified as Child-Pugh C
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cross Infection Clostridium Difficile Infection Patients that have stayed in an hospital of the GHICL between January 2013 and September 2015  none
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Infection Hematologic Diseases Bone Marrow Transplant Oncologic Disorders Patients admitted to the hematology oncology inpatient units at Froedtert Memorial Lutheran Hospital New onset of diarrhea during hospitalization C. difficile clinical testing showing NAAT positive EIA negative results  Being unable to consent for self Inability to take enteral medications Unwillingness to enroll in study Patient has a documented allergy to vancomycin Patient has a documented life expectancy shorter than treatment course (14 days) Patient is unwilling or unable to provide stool samples in the outpatient setting after discharge Diagnosis of C. difficile colitis [NAAT (+) and toxin EIA (+) within 3 months of enrollment) New onset of abdominal distention within 24 hours prior to the onset of diarrhea during index admission Presence of toxic megacolon Presence of clinical sepsis. Sepsis will be defined as a Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score of 2 points or more as per 2016 definitions
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 40.0-90.0,  Propionibacterium Acnes Patients undergoing primary shoulder arthroplasty  Patients with prior shoulder surgery Patients with a symptomatic infection or history of infection, recent antibiotic use (within six weeks), or with clinical signs of infection such as an elevated ESR, CRP, positive aspiration cultures, or positive biopsy Patients with a known hypersensitivity to hydrogen peroxide